Clinical Validation of mμSORS for Noninvasive Blood Glucose Detection

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 8, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 1, 2023

Conditions
Diabetes MellitusMedical Device
Interventions
DEVICE

Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose Detection

Blood glucose of participants were measured by venous plasma and multi-channel microspatial offset Raman scattering spectroscopy (mμSORS). The two measurements were collected synchronously and analyzed.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Photonic View Technology Co., Ltd.

UNKNOWN

lead

Shanghai Jiao Tong University School of Medicine

OTHER